Phenelzine (or NARDIL®) is mainly prescribed to treat treatment-resistant major depressive disorder, dysthymia, bipolar depression, panic disorder, social anxiety disorder, bulimia nervosa, and post-traumatic stress disorder.
Class: Monoamine Oxidase Inhibitor (MAOI)
FDA Approval: 1961
Dosage Forms: 15 mg
Biological Half-life: 11.6 hours
Side Effects: Dizziness, drowsiness, tiredness, weakness, insomnia, constipation, upset stomach, dry mouth, decreased urination, erectile dysfunction, increased suicide risk
Routes of Administration: Oral
Pregnancy Category: C (US)